# Nutraq as · 99-39 · NORWAY — FDA import alert red lists: firms subject to detention without physical examination

For Nutraq as · 99-39 · NORWAY, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is NORWAY; product is ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan; product code is 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 05/05/2015; address is Enebakkveien 117 , Oslo, NO-03 NORWAY, verified against its source on 2026-09-16.

- **Firm:** Nutraq as _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** NORWAY _(verified: appears in the quote below)_
- **Address:** Enebakkveien 117 , Oslo, NO-03 NORWAY _(verified: appears in the quote below)_
- **Date published:** 05/05/2015 _(verified: appears in the quote below)_
- **Product code:** 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. _(verified: each item appears in the quote below)_
- **Product:** ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan _(verified: each item appears in the quote below)_
- **FDA notes:** The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 _(verified: each item appears in the quote below)_

## What the source says

> Nutraq as Date Published : 05/05/2015 Enebakkveien 117 , Oslo, NO-03 NORWAY 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 46 Y - - 99 Food Additives For Human Use, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 46 Y - - 99 Food Additives For Human Use, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 A - - 99 Vitamin, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 A - - 99 Vitamin, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).